Company news

Kwang Dong Pharmaceutical Co., Ltd. news in 2025

Kwang Dong Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

September 15, 2025